Findings from a recent study illustrate why you should be talking with your pregnant patients about their consumption of fatty acids.
Preterm birth is the leading cause of perinatal mortality and morbidity in the United States and also very difficult to predict. A research group at Stanford University believes they may have found an indicator.
A large, retrospective study confirms that birth at age ≥ 40 confers a heightened risk of preterm birth (PTB) (< 37 weeks) and very preterm birth (< 32 weeks).
Women who undergo loop electrosurgical excision procedure (LEEP) for treatment of cervical intraepithelial neoplasia (CIN) grade 1 and subsequently deliver are at increased risk for preterm birth (PTB), according to recently published research.
Altered maternal vaginal microbiota composition contributes to the pathophysiology of preterm birth (PTB), according to a study of two racially distinct cohorts of US pregnant women.
In cases of very preterm birth, waiting at least 2 minutes to clamp the umbilical cord, coupled with immediate neonatal care with the cord intact, improved outcomes, according to a multicenter study.
Results of a UK study show that while intrauterine infection may contribute to preterm birth (PTB), a reproducible “preterm placental microbiome” does not exist. Plus: Depression in the male partner of couples being treated for infertility was linked to lower pregnancy chances, according to results of a recent study.
Maternal chronic hepatitis B virus (HBV) infection is associated with a 16% increase in risk of preterm birth (PTB), with substantial heterogeneity, according to an updated systematic review and meta-analysis.
The fetal fibronectin (fFN) test alone had a sensitivity of 66.7% and a specificity of 97.2% in predicting spontaneous preterm birth (SPTB) in symptomatic twin pregnancies, according to a small pilot study of 40 women.
Identifying and Counseling Patients at Risk for Recurrent Preterm Birth. Improving Women’s Understanding of Recurrent Preterm Birth. Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline on Reducing the Risk of Preterm Birth and Potential Treatment in Certain At-Risk Women. Strategies for implementing the SMFM clinical guideline for reducing the risk of preterm birth in women with a history of recurrent preterm birth.